Company Indivior PLC

Equities

INDV

GB00BN4HT335

Pharmaceuticals

Market Closed - London S.E. 11:35:27 2024-07-17 am EDT 5-day change 1st Jan Change
831 GBX +6.13% Intraday chart for Indivior PLC +6.54% -29.87%

Business Summary

Indivior PLC is a pharmaceutical company. The Company develops medicines to treat addiction and serious mental illnesses. The Company focuses on building a portfolio of opioid dependence treatments. It has a pipeline of product candidates designed to address other chronic conditions and co-occurring disorders of addiction, including alcohol use disorder. Its product pipeline focuses on development and discovery of non-opioid treatment strategies for opioid use disorder (OUD), as well as therapies to address the needs of people suffering from alcohol, stimulant, and cannabis use disorders. Its Sublocade, Subutex, and Suboxone are used for the treatment of opioid use disorder (OUD). Perseris is used for the treatment of Schizophrenia. The Company's pipeline products include AEF0117, INDV-2000, INDV-1000, RBP-6000, RBP-7000, Buprenorphine Sublingual and Naloxone Film, and Buprenorphine and Naloxone Sublingual Tablet. Its pipeline also includes the Orexin-1 Receptor Antagonist Program.

Number of employees: 1,000

Sales per Business

GBP in Million2022Weight2023Weight Delta
Buprenorphine-based Prescription Drugs
100.0 %
731 100.0 % 879 100.0 % +20.21%

Sales per region

GBP in Million2022Weight2023Weight Delta
United States
83.4 %
593 81.1 % 734 83.4 % +23.63%
Rest of World
16.1 %
133 18.2 % 142 16.1 % +6.34%
United Kingdom
0.5 %
5 0.7 % 4 0.5 % -17.42%

Managers

Managers TitleAgeSince
Chief Executive Officer - 11-12-31
Director of Finance/CFO - 11-12-31
Compliance Officer - 18-09-30
Chief Tech/Sci/R&D Officer - 14-11-30
Public Communications Contact 50 15-07-14
Investor Relations Contact - -
Corporate Officer/Principal - -
Corporate Officer/Principal - -
Human Resources Officer - 14-09-30
Corporate Officer/Principal - -

Members of the board

Members of the board TitleAgeSince
Chairman 65 19-10-31
Director/Board Member 64 22-05-31
Director/Board Member 61 21-03-23
Director/Board Member 48 21-03-23
Director/Board Member 66 19-07-31
Chief Executive Officer - 11-12-31
Director/Board Member 57 21-03-23
Director/Board Member 60 21-03-23
Director of Finance/CFO - 11-12-31
Director/Board Member - Nov. 08

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 133,895,931 129,505,436 ( 96.72 %) 0 96.72 %

Shareholders

NameEquities%Valuation
Two Seas Capital LP
9.893 %
13,260,025 9.893 % 208 M p
Two Seas Capital LP
9.887 %
13,251,002 9.887 % 208 M p
Morgan Stanley & Co. International Plc
7.268 %
9,741,226 7.268 % 153 M p
Oaktree Capital Management LP
6.337 %
8,493,173 6.337 % 133 M p
Société Générale Gestion SA
5.048 %
6,766,479 5.048 % 106 M p
Scopia Capital Management LP
4.693 %
6,289,509 4.693 % 99 M p
Fidelity Management & Research Co. LLC
4.646 %
6,226,815 4.646 % 98 M p
Scopia Capital Management LP
4.495 %
6,025,233 4.495 % 94 M p
Vanguard Fiduciary Trust Co.
4.411 %
5,911,716 4.411 % 93 M p
Goldman Sachs Asset Management LP
3.477 %
4,660,387 3.477 % 73 M p

Holdings

NameEquities%Valuation
701,469 5.29% 9,623,032 $

Company contact information

Indivior PLC

10710 Midlothian Turnpike Suite 125

23235, North Chesterfield

+804 379 1090

http://indivior.com
address Indivior PLC(INDV)

Group companies

NameCategory and Sector
Financial Conglomerates